Myocarditis Thailand Study: Experts React
Experts point out that the US has not run any of their own studies, and the FDA asked the companies to produce them, but they have yet to either.
The Thailand study on myocarditis, Cardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents has some surprising findings. Unfortunately, it is a small study but it is the only one of its kind that we currently have, as many point out below.
(Study link: https://www.preprints.org/manuscript/202208.0151/v1)
Although the pre-print study is not officially published yet, According to Tracy Hoeg, the study has been approved for publication, meaning it has passed peer review.
For an overview of the study, here’s Doctor John Campbell discussing the Thailand study on myocarditis.
YouTube typically highly censors information related to the vaccine, but John tries to only analyze government data and published studies and so evades censorship by avoiding speculation.
The study has received almost zero media coverage, other than some “fact check” commentary:
The study looked at more than heart rhythm changes. Here is Dr. Anish Koka’s analysis of the Thailand Study: 3 out of 301 developed myocarditis and 4 additional children developed subclinical myocarditis:
As Koka says, “Multiple datasets from around the globe from countries with much smaller budgets than our CDC have suggested higher rates than what the CDC reports. A nice comprehensive review from Hoeg, Stevenson & Krug last year demonstrates the discrepancy well.”
Here is a chart from that comprehensive review of myocarditis studies:
The Highwire also looked at the study and provided a chart of cardiovascular effects.
Among other points, Dr. Vinay Prasad observes that all spike-protein vaccines are causing the myocarditis issue, so it can’t be explained as an mRNA problem, only. He also reviews some of the earlier studies showing a rate of 1 in 3000-5000 young men developing myocarditis:
Later in the same substack post:
Anish Koka’s post also summarizes some data on previous Myocarditis studies and makes the important observation that it is “entirely possible that there are severe cases of myocarditis that result in out of hospital death that are never labeled as myocarditis.”
Many make the point that the US should be running studies on myocarditis to determine any subclinical issues.
Florida’s Surgeon General comments on the Thailand study, which found 3.5% rate of “overt or subclinical myocarditis… is @CDCgov doing a similar prospective study in the US? Is anyone?”:
In a related observation, Dr. Marty Makary points out that US institutions have spent billions of dollars researching long-COVID (after-effects of a COVID infection), but almost nothing on research into heart injury in children.
As Dr. Clare Craig says, the FDA instructed the vaccine companies to run these studies, but they have not yet done so.
Dr. Peter McCullough also makes this point in his interview with Kim Iversen. He also discusses subclinical myocarditis:
Because I can’t embed the video in this substack, here is a direct link to the Dr. McCullough interview: https://rumble.com/v1fs6r6-alarmingly-high-rates-of-teen-myocarditis-found-in-thailand-preprint-1-in-4.html
Also noteworthy is that there are zero long-term studies of any kind on long-term outcomes from these documented cases of myocarditis and subclinical myocarditis caused by COVID vaccines. But we do have historical mortality studies from this condition, which I have summarized.
Notice: I use Twitter screenshots without links because Twitter can instantly remove anyone from their platform, which will remove all of these tweets from existence at any time in the future. Major scientific experts and doctors have been removed from the platform. If you want to find the tweets, look at the user name and date of the tweets, all captured in the screenshots for reference.
Update 2022-08-21: a few days after publishing this, Dr. Clare Craig was permanently suspended from Twitter.